There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
2 responses
1,207 views
0 reactions
|
by SNPsaurus
11-10-2015, 10:12 PM
|
|||
|
5 responses
1,933 views
0 reactions
|
by fpj
11-10-2015, 12:47 AM
|
|||
|
1 response
1,124 views
0 reactions
|
11-08-2015, 11:58 PM
|
|||
|
4 responses
3,515 views
0 reactions
|
by lukeSeq
11-07-2015, 07:03 PM
|
|||
|
1 response
1,588 views
0 reactions
|
11-06-2015, 06:19 PM
|
|||
|
3 responses
2,211 views
0 reactions
|
11-06-2015, 01:04 AM
|
|||
|
1 response
1,310 views
0 reactions
|
by kerplunk412
11-05-2015, 03:44 PM
|
|||
|
1 response
2,808 views
0 reactions
|
by Pab77
11-05-2015, 02:02 AM
|
|||
|
0 responses
1,533 views
0 reactions
|
by Pab77
11-04-2015, 02:07 PM
|
|||
|
2 responses
2,779 views
0 reactions
|
by adam.geber
11-04-2015, 12:54 PM
|
No topics found.
-
Next-generation sequencing (NGS) is now central to outbreak investigations and antimicrobial resistance tracking. Through sophisticated...07-31-2026, 07:00 AM
-
The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.
This convergence of genetics, immunology, and computation...09-01-2026, 05:41 AM -
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM
